Interventional Rhythm Management, Inc. Secures $20 Million in Series B Financing

Research Triangle Park, NC - May 12, 2005 - IRM, Inc., an early stage cardiology company dedicated to the management of patients with cardiac arrhythmias and heart failure, announced today that it has raised $20 Million in Series B Financing. The financing included new investor Johnson & Johnson Development Corporation (JJDC) in addition to previous investors.

IRM was founded in 2003 and incubated by Synecor LLC in the field of cardiac electrophysiology. Synecor, LLC is an accelerator of innovative medical technology with offices located in Research Triangle Park, NC, Portola Valley, CA, and Santa Rosa, CA. SyneCor has assembled significant scientific, financial, and corporate partnerships that participate in the SyneCor incubation model.

top